The CHORUS (Cerivastatin in Heart Outcomes in Renal Disease: Understanding Survival) protocol: A double-blind, placebo-controlled trial in patients with ESRD
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- January 2001
has subject area
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Adult (MeSH)
- Aged (MeSH)
- Aged, 80 and over (MeSH)
- Area Under Curve (MeSH)
- Double-Blind Method (MeSH)
- Female (MeSH)
- Follow-Up Studies (MeSH)
- Heart (MeSH)
- Humans (MeSH)
- Hydroxymethylglutaryl-CoA Reductase Inhibitors (MeSH)
- Kidney Failure, Chronic (MeSH)
- Male (MeSH)
- Middle Aged (MeSH)
- Multicenter Studies as Topic (MeSH)
- Pyridines (MeSH)
- Randomized Controlled Trials as Topic (MeSH)
- Renal Dialysis (MeSH)
- Research Design (MeSH)
- Survival Analysis (MeSH)
- Urology & Nephrology (Science Metrix)